By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



793 Darby Paoli Road

Bryn Mawr  Pennsylvania  19010-1145  U.S.A.
Phone: 610-800-2443 Fax: n/a



Company News
Oncoceutics Release: Research Publications Provide Rationale For ONC201 Trials In Breast Cancer 5/9/2017 10:41:06 AM
Oncoceutics Release: Fox Chase Cancer Center Enrolling Patients In ONC201 Multiple Myeloma Trial 5/1/2017 10:02:06 AM
Oncoceutics Presentations On ONC201 And Other Imipridones At AACR 2017 3/28/2017 10:22:08 AM
Oncoceutics Release: ONC201 Phase I Trial Results Reported In Clinical Cancer Research 3/28/2017 10:18:56 AM
Oncoceutics Expands DRD2 Research Collaborations With NIH 3/16/2017 1:38:31 PM
Oncoceutics Promotes Lee Schalop, MD, To Chief Operating Officer 11/23/2016 9:45:48 AM
Oncoceutics Release: Imipridone Activity Described In Multiple Abstracts At 2016 American Society of Hematology Meeting 11/16/2016 11:12:36 AM
Oncoceutics Receives Additional US Patent For ONC201 In Adenocarcinomas 9/29/2016 8:47:35 AM
Oncoceutics Release: Oncotarget Article Describes Development Of Imipridone ONC201 9/16/2016 9:14:28 AM
Oncoceutics Release: ONC201 Continues To Show Excellent Safety When Dosed Weekly 9/12/2016 11:05:13 AM